Continuous glucose monitoring device

• US 20050137471A1
• Filed: 12/18/2003
• Published: 06/23/2005
• Est. Priority Date: 12/18/2003
• Status: Abandoned Application

• Current Assignee: Roche Diabetes Care Inc. (Roche Holding AG)
• Original Assignee: Roche Diabetes Care Inc. (Roche Holding AG)
• Inventors: Baader, Felix, List, Hans, Harttig, Herbert, Haar, Hans-Peter, Meacham, George Bevan Kirby
• Application Number:
  US10/740,056
• Publication Number:
  US 20050137471A1
• Time in Patent Office: Days
• US Class Current: 600/365
• CPC Class Codes: A61B 2562/0295 Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157 disposable multilayered or laminated electrodes G01N27/307; details of handling chemical test elements G01N33/4875
• CPC Class Codes: A61B 5/14528 invasively
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/686 Permanently implanted devices, e.g. pacemakers, other stimulators, biochips A61B5/6861 takes precedence
• CPC Class Codes: Y10T 436/110833 Utilizing a moving indicator strip or tape

Abstract

The present invention is generally directed towards devices for sensing a concentration of chemical constituents in body fluid such as interstitial fluid, including but not limited to glucose. The devices also relates to systems for measuring and reporting the concentration of body fluid constituents at time intervals shorter than the physiological response time, thereby providing effectively continuous concentration measurements. The device according to the present invention comprises a probe, a reservoir with perfusion fluid connected to an inlet of the probe, at least one test zones which comprise a reagent, to react with the analyte to produce a detectable change, a reader unit which reads test zones wetted with fluid containing the analyte, where the reader unit produces signals according to the concentration of the analyte in the fluid; and a processing unit for processing the signals and the concentration of the analyte.

Claims

1. A system for monitoring analyte concentrations comprising:

an implantable probe;

a reservoir with perfusion fluid connected to an inlet of the probe;

a means for storing multiple test zones which comprise a reagent, wherein the reagent reacts with the analyte to produce a detectable change,

an exposure section for exposing at least one of the test zones to receive fluid containing the analyte from an outlet of the probe;

a transport means for transporting the at least one test zones to the exposure section for receiving fluid containing the analyte and for transporting used test zones into a storage section;

a reader unit which reads test zones wetted with fluid containing the analyte, wherein the reader unit produces signals according to the concentration of the analyte in the fluid; and

a processing unit for processing the signals and to calculate the concentration of the analyte in the fluid.

2. The system according to claim 1, wherein the implantable probe is a microdialysis probe and the fluid containing analyte is a microdialysate.

3. The system according to claim 1, wherein the implantable probe is a microperfusion probe and the fluid containing analyte is a microperfusate.

4. The system according to claim 1, wherein the means comprises a testing tape with said multiple test zones.

5. The system according to claim 4, wherein the testing tape comprises multiple test zones affixed to a transport tape.

6. The system according to claim 4, wherein an unused portion of the testing tape is wound on a storage reel and a used portion of the testing tape is wound on a waste reel.

7. The system according to claim 1, wherein the outlet of the probe is adapted to form an exposed drop of fluid when fluid leaves the outlet and the drop contacts the test zone.

8. The system according to claim 1, wherein the test zones produce an optically detectable change when analyte is present in the fluid and the reader performs an optical reading of the optical change.

9. The system according to claim 1, further comprising a pump for pumping perfusion fluid into the inlet of the probe.

10. The system according to claim 1, comprising a pump for sucking fluid out of the probe.

11. The system according to claim 1, further comprising a control unit which controls the transport of test zones, reading of test zones and the contacting of test zones with fluid from the probe.

12. The system according to claim 11, wherein the control unit further controls a pump to discharge fluid from the probe onto the test zones.

13. The system according to claim 12, wherein said control unit controls the pump to discharge fluid which actually hasn'"'"'t been equilibrated with body fluid from the probe before discharging further fluid onto a fresh test zone.

14. The system according to claim 13, wherein the discharge of not equilibrated fluid is made onto an already used test zone.

15. The system according to claim 12, wherein said pump after discharge of fluid onto a test zone sucks fluid from a region of the probe which does not equilibrate with body fluid back into an exchange region.

16. The system according to claim 1, having a circulating means to circulate fluid within the probe.

17. A system for monitoring an analyte concentrations comprising:

an implantable probe;

a magazine for storing multiple single use test elements that receives the analyte to produce a detectable change;

a reservoir with perfusion fluid connected to an inlet of the probe;

an application section for applying fluid containing analyte from an outlet of the probe to at least one of the single use test elements;

a transport means which transports the single use test elements to the application section for receiving fluid containing analyte and for transporting used single use test elements into a storage section;

a reader unit which reads the single use test elements wetted with fluid containing analyte and which produces signals according to the concentration of the analyte in the fluid; and

a processing unit for processing the signals and to calculate the concentration of analyte in the fluid.

18. A method of determining an effective diffusion constant k representing the membrane behavior of an implanted microdialysis membrane, comprising:

measuring an analyte concentration of a fluid containing the analyte at different equilibration times; and

comparing said concentration values to obtain the effective diffusion constant k

19. The method according to claim 18 wherein the value of the effective diffusion constant k is used as an indicator of the microdialysis membrane condition and as a control parameter to initiate specific actions.